{"resourceType":"CodeSystem","id":"other-immunotherapy-codesystem","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>https://hapi.fhir.tw/fhir/CodeSystem/other-immunotherapy-codesystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">00<a name=\"other-immunotherapy-codesystem-00\"> </a></td><td>(1)未接受免疫治療，免疫治療非首次療程的一部份 (2)由屍體解剖而診斷為癌症</td></tr><tr><td style=\"white-space:nowrap\">01<a name=\"other-immunotherapy-codesystem-01\"> </a></td><td>接受全身性免疫藥物治療</td></tr><tr><td style=\"white-space:nowrap\">02<a name=\"other-immunotherapy-codesystem-02\"> </a></td><td>接受局部性免疫藥物治療</td></tr><tr><td style=\"white-space:nowrap\">03<a name=\"other-immunotherapy-codesystem-03\"> </a></td><td>接受全身性與局部性免疫藥物治療</td></tr><tr><td style=\"white-space:nowrap\">04<a name=\"other-immunotherapy-codesystem-04\"> </a></td><td>僅接受免疫細胞治療</td></tr><tr><td style=\"white-space:nowrap\">05<a name=\"other-immunotherapy-codesystem-05\"> </a></td><td>同時接受免疫細胞治療與全身性免疫藥物治療</td></tr><tr><td style=\"white-space:nowrap\">06<a name=\"other-immunotherapy-codesystem-06\"> </a></td><td>同時接受免疫細胞治療與局部性免疫藥物治療</td></tr><tr><td style=\"white-space:nowrap\">07<a name=\"other-immunotherapy-codesystem-07\"> </a></td><td>同時接受免疫細胞治療、全身性與局部性免疫藥物治療</td></tr><tr><td style=\"white-space:nowrap\">20<a name=\"other-immunotherapy-codesystem-20\"> </a></td><td>僅接受臨床試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">21<a name=\"other-immunotherapy-codesystem-21\"> </a></td><td>同時接受全身性或/與局部性免疫藥物治療及臨床試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">22<a name=\"other-immunotherapy-codesystem-22\"> </a></td><td>同時接受免疫細胞治療及臨床試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">23<a name=\"other-immunotherapy-codesystem-23\"> </a></td><td>同時接受免疫細胞治療與全身性或/與局部性免疫藥物治療及臨床試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">30<a name=\"other-immunotherapy-codesystem-30\"> </a></td><td>僅接受雙盲試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">31<a name=\"other-immunotherapy-codesystem-31\"> </a></td><td>同時接受全身性或/與局部性免疫藥物治療及雙盲試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">32<a name=\"other-immunotherapy-codesystem-32\"> </a></td><td>同時接受免疫細胞治療及雙盲試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">33<a name=\"other-immunotherapy-codesystem-33\"> </a></td><td>同時接受免疫細胞治療與全身性或/與局部性免疫藥物治療及雙盲試驗免疫治療</td></tr><tr><td style=\"white-space:nowrap\">99<a name=\"other-immunotherapy-codesystem-99\"> </a></td><td>(1)由於病歷未記載，所以不知道是否免疫治療有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症</td></tr></table></div>"},"url":"https://hapi.fhir.tw/fhir/CodeSystem/other-immunotherapy-codesystem","version":"0.1.0","name":"OtherImmunotherapyCS","title":"Other Immunotherapy Code System","status":"draft","experimental":false,"date":"2023-09-06T16:47:50+08:00","publisher":"Kuo","contact":[{"name":"Kuo","telecom":[{"system":"url","value":"http://example.org/example-publisher"}]}],"description":"Other Immunotherapy Code System","caseSensitive":true,"content":"complete","count":17,"concept":[{"code":"00","display":"(1)未接受免疫治療，免疫治療非首次療程的一部份 (2)由屍體解剖而診斷為癌症"},{"code":"01","display":"接受全身性免疫藥物治療"},{"code":"02","display":"接受局部性免疫藥物治療"},{"code":"03","display":"接受全身性與局部性免疫藥物治療"},{"code":"04","display":"僅接受免疫細胞治療"},{"code":"05","display":"同時接受免疫細胞治療與全身性免疫藥物治療"},{"code":"06","display":"同時接受免疫細胞治療與局部性免疫藥物治療"},{"code":"07","display":"同時接受免疫細胞治療、全身性與局部性免疫藥物治療"},{"code":"20","display":"僅接受臨床試驗免疫治療"},{"code":"21","display":"同時接受全身性或/與局部性免疫藥物治療及臨床試驗免疫治療"},{"code":"22","display":"同時接受免疫細胞治療及臨床試驗免疫治療"},{"code":"23","display":"同時接受免疫細胞治療與全身性或/與局部性免疫藥物治療及臨床試驗免疫治療"},{"code":"30","display":"僅接受雙盲試驗免疫治療"},{"code":"31","display":"同時接受全身性或/與局部性免疫藥物治療及雙盲試驗免疫治療"},{"code":"32","display":"同時接受免疫細胞治療及雙盲試驗免疫治療"},{"code":"33","display":"同時接受免疫細胞治療與全身性或/與局部性免疫藥物治療及雙盲試驗免疫治療"},{"code":"99","display":"(1)由於病歷未記載，所以不知道是否免疫治療有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症"}]}